Stock Markets June 17, 2026 02:26 PM

BMO Elevates Solstice Advanced Materials As Top U.S. Chemicals Pick

Bank raises target to $101, citing strong positioning in uranium and upgraded earnings outlook

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
SOLS

BMO Capital Markets has updated its U.S. chemicals coverage and designated Solstice Advanced Materials (SOLS) as a Top Pick, increasing its price target to $101 after reviewing the company’s uranium platform and related presentation by company and ConverDyn executives. The firm cites secular growth potential and raised its target multiple based on greater confidence in the business's earnings trajectory. Solstice reported first-quarter revenue above guidance and posted an EPS of $0.63; Truist Securities began coverage with a Hold and a $90 target.

BMO Elevates Solstice Advanced Materials As Top U.S. Chemicals Pick
SOLS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • BMO Capital Markets named Solstice Advanced Materials (SOLS) a Top Pick and raised its target price to $101.
  • The upgrade followed a presentation on Solstice’s uranium business by SOLS Senior Vice President Jeff Dormo and ConverDyn CEO Malcolm Critchley and incorporated BMO’s independent research.
  • Solstice reported first-quarter revenue of $991 million, above guidance, and an EPS of $0.63; Truist Securities initiated coverage with a Hold and a $90 target.

BMO Capital Markets has refreshed its coverage of the U.S. chemicals sector and highlighted a roster of companies it views as well positioned for growth. Among those, Solstice Advanced Materials (SOLS) stands out as a Top Pick following a focused review of its nuclear materials business.

The upgrade of SOLS to Top Pick included a target-price increase to $101. BMO's decision followed a detailed presentation on Solstice’s uranium operations delivered by Solstice Senior Vice President Jeff Dormo alongside ConverDyn Chief Executive Officer Malcolm Critchley. The analysts said the presentation, together with their own research, reinforced confidence in the company’s near- to medium-term earnings prospects.

BMO characterized Solstice’s nuclear platform as one of the firm’s most valuable assets, citing expectations for significant secular growth through the end of the decade. The firm noted it raised the target multiple applied to SOLS to reflect that heightened confidence in the earnings outlook for the nuclear materials business. BMO’s assessment rested on both information supplied by Solstice management and independent analysis of the nuclear materials space.

Solstice reported first-quarter revenue of $991 million, a result the company said exceeded its prior guidance. The firm also recorded diluted earnings per share of $0.63 for the quarter. In addition to the BMO coverage change, Truist Securities has initiated coverage on Solstice with a Hold rating and set a $90.00 price target.

Overall, BMO’s updated sector work emphasizes companies that present secular growth opportunities and possess competitive advantages in their markets. The bank’s focus for its coverage update has been on businesses with solid fundamentals and sustainable growth drivers.


Impacted sectors - Chemicals, industrial materials, energy and nuclear-related supply chains.

Context limits - The conclusions and ratings described derive from the information provided to BMO by Solstice management as well as the bank’s independent research; the update reflects BMO’s analysis rather than new operational developments announced by Solstice in the release.

Risks

  • Reliance on management-provided information - BMO’s revised target multiple and confidence in earnings were informed by details provided by Solstice management as well as the bank’s research; the assessment depends on the accuracy and completeness of that information.
  • Market and sector uncertainty - The anticipated secular growth for the nuclear materials platform is projected through the end of the decade, but future performance will be subject to broader market and sector conditions that can affect chemicals and energy supply chains.

More from Stock Markets

Moody's Elevates ICU Medical to Ba3, Citing Expected Lower Leverage and Strong Cash Flow Jun 17, 2026 Mingteng Shares Plunge After Discounted $2.96M Registered Direct Offering Jun 17, 2026 Bernstein Flags Energy Drinks as Engine for CPG Recovery; Picks Top Stocks to Watch Jun 17, 2026 Activist TOMS Capital Presses Devon Energy to Speed Asset Sales or Consider Sale of Company Jun 17, 2026 Options Volume Surges in Sezzle Contracts, July Calls Draw the Most Interest Jun 17, 2026